Larvol Delta - CervoMeds-anticipated-milestones-for-the-remainder-of-2026-subject-to-available-funding-include

neflamapimod (VX-745) - CervoMed

https://finance.yahoo.com/sectors/healthcare/articles/cervomed-reports-first-quarter-2026-113000563.html

May 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next